ARCHIVES

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

This article is from The Cancer Letter archive.

Vol. 25 No. 46 | December 3, 1999

Download PDF Visit The Full Archive

Related Articles

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

Pres. Bill Clinton to Serve as Honorary Chair Of NBCC’s Breast Cancer Deadline 2020

November 16, 2012